BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 20534251)

  • 1. The role of immunosuppression in malignancies among 351 pediatric renal transplant patients.
    Berardinelli L; Raiteri M; Ghio L; Messa PG; Montagnino G
    Transplant Proc; 2010 May; 42(4):1166-8. PubMed ID: 20534251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. De novo malignancies after renal transplantation--a single-center experience in the Balkans.
    Popov Z; Ivanovski O; Kolevski P; Stankov O; Petrovski D; Cakalaroski K; Ivanovski N
    Transplant Proc; 2007 Oct; 39(8):2589-91. PubMed ID: 17954184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; CurrĂ² G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Annual trends and triple therapy--1991-2000.
    Nishikawa K; Terasaki PI
    Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronologically different incidences of post-transplant malignancies in renal transplant recipients: single center experience.
    Ju MK; Joo DJ; Kim SJ; Huh KH; Kim MS; Jeon KO; Kim HJ; Kim SI; Kim YS
    Transpl Int; 2009 Jun; 22(6):644-53. PubMed ID: 19220824
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of donor source, recipient age, pre-operative immunotherapy and induction therapy on early and late acute rejections in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).
    Tejani AH; Stablein DM; Sullivan EK; Alexander SR; Fine RN; Harmon WE; Kohaut EC
    Pediatr Transplant; 1998 Nov; 2(4):318-24. PubMed ID: 10084737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Results of pediatric kidney transplantation at the University of Minnesota.
    Chavers BM; Matas AJ; Nevins TE; Mauer SM; Sutherland DE; Payne W; Dunn D; Gillingham K; Najarian JS
    Clin Transpl; 1989; ():253-66. PubMed ID: 2487570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal transplantation in children. A report of the North American Pediatric Renal Transplant Cooperative Study.
    McEnery PT; Stablein DM; Arbus G; Tejani A
    N Engl J Med; 1992 Jun; 326(26):1727-32. PubMed ID: 1594014
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early de novo malignancies after kidney transplantation.
    Veroux M; Puliatti C; Fiamingo P; Cappello D; Macarone M; Puliatti D; Vizcarra D; Gagliano M; Veroux P
    Transplant Proc; 2004 Apr; 36(3):718-20. PubMed ID: 15110643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal transplantation in primary focal segmental glomerulosclerosis using a tolerance induction protocol.
    Suthar K; Vanikar AV; Trivedi HL
    Transplant Proc; 2008 May; 40(4):1108-10. PubMed ID: 18555125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignancies after kidney transplantation.
    Rascente M; Pisani F; Barletta A; D'Angelo M; Giammaria A; Parzanese I; Rizza V; Iaria G; Famulari A
    Transplant Proc; 2005; 37(6):2529-31. PubMed ID: 16182735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignancies in renal transplant patients: 15 years experience in Thailand.
    Ativitavas T; Jirasiritham S; Ngorsakun P; Pipatpannawong K; Mavichak V
    Transplant Proc; 2008 Sep; 40(7):2403-4. PubMed ID: 18790248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superior long-term results of renal transplantation in children under 5 years of age.
    Ojogho O; Sahney S; Cutler D; Abdelhalim F; Hasan M; Baron P; Concepcion W
    Am Surg; 2002 Dec; 68(12):1115-9. PubMed ID: 12516821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mortality in pediatric renal transplants: 15 years' experience].
    Harzallah K; Floret D; Martin X; Cochat P
    Arch Pediatr; 2004 Aug; 11(8):916-20. PubMed ID: 15288081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved 24-hour blood pressure control with sirolimus versus calcineurin inhibitor based immunosuppression in renal transplant recipients.
    Steigerwalt SP; Brar N; Dhungel A; Butcher D; Steigerwalt S; El-Ghouroury M; Provenzano R
    Transplant Proc; 2009 Dec; 41(10):4184-7. PubMed ID: 20005365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malignancy following kidney transplantation.
    Arichi N; Kishikawa H; Nishimura K; Mitsui Y; Namba Y; Tokugawa S; Ichikawa Y
    Transplant Proc; 2008 Sep; 40(7):2400-2. PubMed ID: 18790247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The UNOS Scientific Renal Transplant Registry.
    Cecka JM
    Clin Transpl; 1999; ():1-21. PubMed ID: 11038622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in proteinuria and graft function in de novo sirolimus-based vs. calcineurin inhibitor-based immunosuppression in live donor kidney transplantation.
    Stephany BR; Augustine JJ; Krishnamurthi V; Goldfarb DA; Flechner SM; Braun WE; Hricik DE; Dennis VW; Poggio ED
    Transplantation; 2006 Aug; 82(3):368-74. PubMed ID: 16906035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy incidence after renal transplantation in children: a 20-year single-centre experience.
    Koukourgianni F; Harambat J; Ranchin B; Euvrard S; Bouvier R; Liutkus A; Cochat P
    Nephrol Dial Transplant; 2010 Feb; 25(2):611-6. PubMed ID: 19820249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 12th Annual Report of the North American Pediatric Renal Transplant Cooperative Study: renal transplantation from 1987 through 1998.
    Seikaly M; Ho PL; Emmett L; Tejani A
    Pediatr Transplant; 2001 Jun; 5(3):215-31. PubMed ID: 11422826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.